Canopy Growth Corporation (WEED.TO)
CAD 1.64
(0.61%)
CAD 1.64
(0.61%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 512.87 Million CAD | -18.58% |
| 2022 | 629.87 Million CAD | -13.12% |
| 2021 | 724.98 Million CAD | 69.27% |
| 2020 | 428.31 Million CAD | 163.23% |
| 2019 | -677.35 Million CAD | 55.87% |
| 2018 | -1.53 Billion CAD | -388.59% |
| 2017 | -314.13 Million CAD | -243.43% |
| 2016 | -91.47 Million CAD | -704.13% |
| 2015 | -11.37 Million CAD | -191.75% |
| 2014 | -3.89 Million CAD | -90.25% |
| 2013 | -2.04 Million CAD | -19899.78% |
| 2012 | -10.24 Thousand CAD | 53.26% |
| 2011 | -21.92 Thousand CAD | -128.96% |
| 2010 | -9576.00 CAD | 74.79% |
| 2009 | -37.98 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 431.37 Million CAD | -15.89% |
| 2023 Q3 | 550.52 Million CAD | 4.9% |
| 2023 Q4 | 512.87 Million CAD | -6.84% |
| 2023 FY | 512.87 Million CAD | -18.58% |
| 2023 Q1 | 601.69 Million CAD | -4.47% |
| 2023 Q2 | 524.78 Million CAD | -12.78% |
| 2022 Q1 | 688.22 Million CAD | -5.07% |
| 2022 Q2 | 607.39 Million CAD | -11.74% |
| 2022 Q3 | 607.47 Million CAD | 0.01% |
| 2022 FY | 629.87 Million CAD | -13.12% |
| 2022 Q4 | 629.87 Million CAD | 3.69% |
| 2021 Q3 | 1.03 Billion CAD | 44.4% |
| 2021 FY | 724.98 Million CAD | 69.27% |
| 2021 Q4 | 724.98 Million CAD | -30.17% |
| 2021 Q2 | 718.98 Million CAD | -36.43% |
| 2021 Q1 | 1.13 Billion CAD | 164.06% |
| 2020 Q1 | -340.14 Million CAD | 49.78% |
| 2020 Q2 | -139.59 Million CAD | 58.96% |
| 2020 Q3 | -55.32 Million CAD | 60.36% |
| 2020 FY | 428.31 Million CAD | 163.23% |
| 2020 Q4 | 428.31 Million CAD | 874.11% |
| 2019 Q2 | -497.97 Million CAD | 50.74% |
| 2019 Q4 | -677.35 Million CAD | 32.53% |
| 2019 Q3 | -1 Billion CAD | -101.6% |
| 2019 Q1 | -1.01 Billion CAD | 34.14% |
| 2019 FY | -677.35 Million CAD | 55.87% |
| 2018 Q2 | 480.75 Million CAD | 1378.34% |
| 2018 FY | -1.53 Billion CAD | -388.59% |
| 2018 Q4 | -1.53 Billion CAD | 53.83% |
| 2018 Q3 | -3.32 Billion CAD | -791.48% |
| 2018 Q1 | -37.6 Million CAD | 88.03% |
| 2017 FY | -314.13 Million CAD | -243.43% |
| 2017 Q4 | -314.13 Million CAD | -37.23% |
| 2017 Q3 | -228.91 Million CAD | -132.08% |
| 2017 Q2 | -98.63 Million CAD | 6.58% |
| 2017 Q1 | -105.58 Million CAD | -15.43% |
| 2016 Q3 | -85.33 Million CAD | -124.94% |
| 2016 FY | -91.47 Million CAD | -704.13% |
| 2016 Q2 | -37.93 Million CAD | -146.36% |
| 2016 Q4 | -91.47 Million CAD | -7.19% |
| 2016 Q1 | -15.39 Million CAD | -35.38% |
| 2015 Q3 | -15.74 Million CAD | -761.76% |
| 2015 Q4 | -11.37 Million CAD | 27.75% |
| 2015 FY | -11.37 Million CAD | -191.75% |
| 2015 Q1 | -13.27 Million CAD | 32.03% |
| 2015 Q2 | -1.82 Million CAD | 86.24% |
| 2014 Q2 | -8.35 Million CAD | 31.77% |
| 2014 Q4 | -19.53 Million CAD | -400.91% |
| 2014 Q3 | -3.89 Million CAD | 53.35% |
| 2014 Q1 | -12.24 Million CAD | -59.9% |
| 2014 FY | -3.89 Million CAD | -90.25% |
| 2013 Q2 | -15.15 Thousand CAD | -47.89% |
| 2013 Q3 | -418.75 Thousand CAD | -2663.33% |
| 2013 Q4 | -7.66 Million CAD | -1729.32% |
| 2013 FY | -2.04 Million CAD | -19899.78% |
| 2013 Q1 | -10.24 Thousand CAD | 15.21% |
| 2012 Q2 | -890.00 CAD | 95.94% |
| 2012 Q4 | -12.08 Thousand CAD | 20.95% |
| 2012 Q3 | -15.28 Thousand CAD | -1617.75% |
| 2012 Q1 | -21.92 Thousand CAD | -0.16% |
| 2012 FY | -10.24 Thousand CAD | 53.26% |
| 2011 FY | -21.92 Thousand CAD | -128.96% |
| 2011 Q4 | -21.89 Thousand CAD | 37.55% |
| 2011 Q3 | -35.05 Thousand CAD | -268.62% |
| 2011 Q2 | -9510.00 CAD | 0.69% |
| 2011 Q1 | -9576.00 CAD | 2.69% |
| 2010 Q1 | -37.98 Thousand CAD | -162.3% |
| 2010 FY | -9576.00 CAD | 74.79% |
| 2010 Q4 | -9841.00 CAD | 42.93% |
| 2010 Q3 | -17.24 Thousand CAD | 44.6% |
| 2010 Q2 | -31.12 Thousand CAD | 18.07% |
| 2009 Q4 | -14.48 Thousand CAD | 0.0% |
| 2009 FY | -37.98 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | -8.64 Million CAD | 6030.527% |
| Avicanna Inc. | 1.32 Million CAD | -38572.326% |
| Avant Brands Inc. | 17.93 Million CAD | -2760.413% |
| Cardiol Therapeutics Inc. | -34.77 Million CAD | 1574.904% |
| Crescita Therapeutics Inc. | -8.13 Million CAD | 6407.613% |
| Knight Therapeutics Inc. | 10.33 Million CAD | -4864.879% |
| MediPharm Labs Corp. | -15.68 Million CAD | 3369.616% |
| OrganiGram Holdings Inc. | -33.7 Million CAD | 1621.469% |
| Willow Biosciences Inc. | -989 Thousand CAD | 51957.634% |
| Auxly Cannabis Group Inc. | 142.88 Million CAD | -258.953% |